Clinical Trial Update: A Study of Tocilizumab in Patients With Rheumatoid Arthritis

View source ↗

Summary

The document reports a completed clinical trial evaluating tocilizumab in patients with rheumatoid arthritis, sponsored by Regeneron.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Rheumatoid Arthritis | Status: COMPLETED